Manon Allaire

机构：Inserm, Sorbonne Université, Centre de Recherche des Cordeliers, Assistance Publique – Hôpitaux de Paris, Immunité et Cancer, Pitié-Salpêtrière Hospital · ORCID：0000-0001-8199-1501

发表论文 43 篇 · 总被引 706 次 · h-index 11

代表论文

• Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study (2025 · The Lancet · 被引 271)
• Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy (2025 · Cellular and Molecular Immunology · 被引 95)
• French guidelines on TIPS : Indications and modalities (2024 · Liver International · 被引 18)
• EASL Clinical Practice Guidelines on extrahepatic abdominal surgery in patients with cirrhosis and advanced chronic liver disease (2025 · Journal of Hepatology · 被引 17)
• International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendations (2023 · BMC Gastroenterology · 被引 9)
• Serum procalcitonin: A novel tumor biomarker for diagnosis and disease monitoring in fibrolamellar hepatocellular carcinoma (2026 · Journal of Hepatology · 被引 5)